Zoladex.net - an international information resource for healthcare professionals with an interest in prostate cancer, provided by AstraZeneca

Welcome to Zoladex.net, an international educational resource for healthcare professionals with an interest in prostate cancer treatment, provided by AstraZeneca. This site is not intended for the following audiences who should use the links below:
US Citizens should visit ProstateInfo.com
UK Patients should visit AstraZeneca.co.uk
UK Physicians should visit CancerLineUK.net
Journalists should visit AstraZenecaPressOffice.com
Patients and carers (non US and non UK) should visit PatientHealthInternational.com.
ZOLADEX is also used for the treatment of breast cancer, please visit ZOLADEX in breast cancer.

Latest news

Features

9 May 2008: ADT more often delayed or withheld in black men with metastatic prostate cancer
9 May 2008: Magnetic nanoparticles show prostate cancer bone-sparing promise
8 May 2008: High dairy protein intake linked to prostate cancer
7 May 2008: ADT patients deviate from 'metabolic syndrome' profile

Drug related information may refer to unlicensed products or uses, which may not be approved in your own country. Please consult your local prescribing information. No information provided on this site should be taken as a recommendation from this website or the site sponsors as to the use of any product.

AstraZeneca websites

Search

Site map

Information for

This is an AstraZeneca International website for healthcare professionals. The site is not intended for the following audiences who should use the links below:

Zoladex news feed

Subscribe via RSS

Quick links

Features

Site services

Printer friendly